Form 8-K - Current report:
SEC Accession No. 0001615219-17-000013
Filing Date
2017-02-02
Accepted
2017-02-02 11:59:14
Documents
5
Period of Report
2017-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20170127form8-k.htm 8-K 26932
2 EXHIBIT 10.1 bostonleasefinal.htm EX-10.1 535235
3 bostonleasefinalimage2a01.jpg GRAPHIC 475675
4 bostonleasefinalimage3a01.jpg GRAPHIC 345264
5 floorplan.jpg GRAPHIC 69415
  Complete submission text file 0001615219-17-000013.txt   1789726
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 17567424
SIC: 2834 Pharmaceutical Preparations